Retinal Degenerative Diseases [electronic resource] / edited by Matthew M. LaVail, John D. Ash, Robert E. Anderson, Joe G. Hollyfield, Christian Grimm.
By: LaVail, Matthew M [editor.].
Contributor(s): Ash, John D [editor.] | Anderson, Robert E [editor.] | Hollyfield, Joe G [editor.] | Grimm, Christian [editor.] | SpringerLink (Online service).
Material type:
BookSeries: Advances in Experimental Medicine and Biology: 723Publisher: Boston, MA : Springer US, 2012Description: LXIV, 864p. 196 illus., 88 illus. in color. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9781461406310.Subject(s): Medicine | Gene therapy | Immunology | Geriatrics | Ophthalmology | Biomedicine | Immunology | Ophthalmology | Geriatrics/Gerontology | Gene TherapyDDC classification: 616.079 Online resources: Click here to access online
In:
Springer eBooksSummary: This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
There are no comments for this item.